© 1996 American Heart Association, Inc.
Articles |
Attenuated Glycogenolysis Reduces Glycolytic Catabolite Accumulation During Ischemia in Preconditioned Rat Hearts
the Peter Belfer Laboratory of the Cardiology Division (R.G.W., C.P. de A., K.V., G.G.), Department of Medicine, and the Division of NMR Research (V.P.C.), Department of Radiology, The Johns Hopkins Hospital, Baltimore, Md.
Correspondence to Robert G. Weiss, MD, Carnegie 584, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287-6568. E-mail rgweiss@rad.jhu.edu.
Prior transient episodes of ischemia ("ischemic preconditioning") reduce lactate accumulation and attenuate acidosis during a subsequent prolonged ischemic insult. The mechanisms responsible for attenuated glycolytic catabolite accumulation have not been established but may include earlier exhaustion of glycogen stores, slowed glycogenolysis before complete glycogen depletion, and/or inhibition of glycolysis. Simultaneous repeated measures of myocardial glycogen and the rates of glycolysis, glycogenolysis, glucose utilization, and glycolytic ATP production were obtained during total ischemia by 13C nuclear magnetic resonance spectroscopy in control and ischemia-preconditioned isolated rat hearts. Both [13C]glycolytic and [13C]glycogenolytic rates were significantly lower during total ischemia in preconditioned compared with control hearts (0.77±0.04 versus 1.06±0.06 µmol/min per gram wet weight [P<.01] for glycolysis and 0.15±0.07 versus 0.78±0.12 µmol/min per gram wet weight [P<.001] for glycogenolysis, respectively, at 2.5 minutes of ischemia). Slowed glycolysis was present even during the early minutes of ischemia, when significant amounts of available [13C]glycogen were still present. Importantly, the reduction in the rate of glycogenolysis was larger and out of proportion to the reduction in glycolysis and occurred despite an increase in glucose utilization in preconditioned hearts (2.23±0.15 versus 1.5±0.10 µmol/min per gram wet weight at 1.25 minutes, P<.01). During early ischemia, conversion of glycogen phosphorylase to the a or "active" form was less in preconditioned than in control hearts (29.1±2.6% versus 41.2±9.8%, respectively; P<.05). Taken together, these findings demonstrate that ischemic preconditioning significantly depresses glycolytic catabolite accumulation during sustained ischemia not by more severe glycolytic inhibition or exhaustion of glycogen stores but by depressed glycogenolysis from the onset of ischemia.
Key Words: glycogen • glycolysis • carbon-13 nuclear magnetic resonance • lactate • phosphorylase
This article has been cited by other articles:
 |
|
 |
|
  J.-H. Yang, L. Yang, Z. Qu, and J. N. Weiss Glycolytic Oscillations in Isolated Rabbit Ventricular Myocytes J. Biol. Chem., December 26, 2008; 283(52): 36321 - 36327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, M. Morgan, R.-F. Shen, C. Steenbergen, and E. Murphy Preconditioning Results in S-Nitrosylation of Proteins Involved in Regulation of Mitochondrial Energetics and Calcium Transport Circ. Res., November 26, 2007; 101(11): 1155 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Tracey, J. L. Treadway, W. P. Magee, J. C. Sutt, R. K. McPherson, C. B. Levy, D. E. Wilder, L. J. Yu, Y. Chen, R. M. Shanker, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1177 - H1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Singh and H. K. Saini Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Weinbrenner, M. Nelles, N. Herzog, L. Sarvary, and R. H Strasser Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway Cardiovasc Res, August 15, 2002; 55(3): 590 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kloner and R. B. Jennings Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 2 Circulation, December 18, 2001; 104(25): 3158 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch Signal transduction of ischemic preconditioning Cardiovasc Res, November 1, 2001; 52(2): 181 - 198. [Full Text] [PDF]
|
|
|
|
|
|
S. Schneider, W. Chen, J. Hou, C. Steenbergen, and E. Murphy Inhibition of p38 MAPK {alpha}/{beta} reduces ischemic injury and does not block protective effects of preconditioning Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H499 - H508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tong, W. Chen, C. Steenbergen, and E. Murphy Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C Circ. Res., August 18, 2000; 87(4): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tong, W. Chen, R. E. London, E. Murphy, and C. Steenbergen Preconditioning Enhanced Glucose Uptake Is Mediated by p38 MAP Kinase Not by Phosphatidylinositol 3-Kinase J. Biol. Chem., April 14, 2000; 275(16): 11981 - 11986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Ganote and S. C. Armstrong Adenosine and preconditioning in the rat heart Cardiovasc Res, January 1, 2000; 45(1): 134 - 140. [Full Text] [PDF]
|
|
|
|
|
|
R. de Jonge and J. W. de Jong Ischemic preconditioning and glucose metabolism during low-flow ischemia: Role of the adenosine A1 receptor Cardiovasc Res, September 1, 1999; 43(4): 909 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer Glucose for the Heart Circulation, February 2, 1999; 99(4): 578 - 588. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gabel, H. R. Cross, R. E. London, C. Steenbergen, and E. Murphy Decreased intracellular pH is not due to increased H+ extrusion in preconditioned rat hearts Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2257 - H2262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schaefer and R. Ramasamy Glycogen utilization and ischemic injury in the isolated rat heart Cardiovasc Res, July 1, 1997; 35(1): 90 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pucar, P. P. Dzeja, P. Bast, N. Juranic, S. Macura, and A. Terzic Cellular Energetics in the Preconditioned State. PROTECTIVE ROLE FOR PHOSPHOTRANSFER REACTIONS CAPTURED BY 18O-ASSISTED 31P NMR J. Biol. Chem., November 21, 2001; 276(48): 44812 - 44819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Forbes, C. Steenbergen, and E. Murphy Diazoxide-Induced Cardioprotection Requires Signaling Through a Redox-Sensitive Mechanism Circ. Res., April 27, 2001; 88(8): 802 - 809. [Abstract] [Full Text] [PDF]
|
|